Showing results (4361-4370 of 5,147) with videos related to
Sort By:
Pageof 515
Vox Sanguinis|December 14, 2011
Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelinesG Lucas, N Win, A Calvert, et al.Vox Sanguinis|December 14, 2011
Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemiaA M Beliaev, R J Marshall, M Gordon, et al.Vox Sanguinis|May 9, 2012
Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trialsJ Cid, G Escolar, M LozanoVox Sanguinis|November 19, 2011
Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmasM Hacquard, T Lecompte, B Belcour, et al.Vox Sanguinis|February 22, 2012
Audit on the usage of plasma derived/recombinant coagulation factor concentrates at a German university hospitalJ Strobel, H Jörns, V Weisbach, et al.Vox Sanguinis|February 1, 2012
Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood ServicesS F O'Brien, Q-L Yi, W Fan, et al.Vox Sanguinis|September 8, 2011
The outcome of donor screening for human T-cell lymphotropic virus infection in The NetherlandsF J Prinsze, H L ZaaijerVox Sanguinis|September 8, 2011
Report of the fourth International Workshop on molecular blood group genotypingG Daniels, C E van der Schoot, M L OlssonVox Sanguinis|July 21, 2011
Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasmaR Norda, U Schött, O Berséus, et al.Vox Sanguinis|October 1, 2011
Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept systemE C VamvakasPageof 515